8-chloroadenosine
Term · Oncology and biomedicine · MLC-T-ONC-009561
An antimetabolite and a chlorine derivative of the purine nucleoside adenosine, with potential antineoplastic activity. Upon administration, 8-chloro-adenosine is phosphorylated to form 8-chloro-adenosine triphosphate (8-chloro-ATP), which functions as a ribonucleoside analogue and competes with ATP during transcription. Therefore, this agent causes RNA synthesis inhibition, inhibits cellular proliferation, and induces apoptosis.
| Identifier | MLC-T-ONC-009561 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 8-Cl-Ado |
| Synonyms | 8-chloro-adenosine; 8-Cl-adenosine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009561",
"term": "8-chloroadenosine",
"field": "Oncology and biomedicine",
"definition": "An antimetabolite and a chlorine derivative of the purine nucleoside adenosine, with potential antineoplastic activity. Upon administration, 8-chloro-adenosine is phosphorylated to form 8-chloro-adenosine triphosphate (8-chloro-ATP), which functions as a ribonucleoside analogue and competes with ATP during transcription. Therefore, this agent causes RNA synthesis inhibition, inhibits cellular proliferation, and induces apoptosis.",
"abbreviation": "8-Cl-Ado",
"synonyms": [
"8-chloro-adenosine",
"8-Cl-adenosine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/8-chloroadenosine/"
}
Record 130 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.